SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
216 V1, I think I remember Coulter had told you it would file a BLA by the end of MHarold Engstrom-6/9/1999
215 Upon reflection, a few things in the release begin to stand out for me. First,Bob L-6/8/1999
214 It might have helped if the release contained some more information. The 58% nuBiomaven-6/8/1999
213 <<Is there some bad news somewhere in this release? >> If there isVector1-6/8/1999
212 Is there some bad news somewhere in this release? The market didn't seem tBob L-6/8/1999
211 Follow up data on Bexxar: biz.yahoo.com DAKLLCF-6/7/1999
210 I must confess I have shorted a biotech or two in the past (Organogenisis comesVector1-5/26/1999
209 Looks like the shorts are taking it in the shorts here so far.... why anyone woLLCF-5/26/1999
208 An ASCO abstract: High Dose Radioiodinated Anti-Cd20 Antibody, Etoposide, CycloBob L-5/19/1999
207 >> interim data from an ongoing Phase II clinical trial to evaluate the escaram(o)uche-4/10/1999
206 Notice that the trial comparing the naked and labeled version has reappeared afBob L-4/10/1999
205 There is some basis for thinking the additional trials mean a delay in the filiBob L-4/10/1999
204 David, News to me. From what I understand is that documentation in connectionVector1-4/5/1999
203 I've heard some negative comments on CLTR, especially their ability to obtaLLCF-4/5/1999
202 valuable research infrastructure working on tumor-activated drugs, but..... tscaram(o)uche-4/1/1999
201 David, check this link and the ones "around it": Message 5509761 InPseudo Biologist-4/1/1999
200 I'm in the process of going back an reading up on CLTR... it seems this stoLLCF-4/1/1999
199 very trueceleryroot.com-3/29/1999
198 Howard: One more comment.... you'll learn about the contributors to SI bscaram(o)uche-3/27/1999
197 Thanks Richard. I will. Howard Bennett-3/27/1999
196 Howard: Suggest that you follow the Munch a Biotech, VD, T/FIF, Biotech Valuatscaram(o)uche-3/27/1999
195 Thanks Richard. I see that you are involved in the field of immunology...are tHoward Bennett-3/27/1999
194 <i>I heard on CNBC today that there have been massive redemptions in Smalscaram(o)uche-3/26/1999
193 10-Feb-99 LUCAS DONALD L Bought (P) 22,900 (i) Common 21.05 - 21.17 Howard Bennett-3/26/1999
192 Notice that this item seems to be prepared for use in TV "news" progrBob L-3/22/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):